Dr. Reddy’s

  • OctoPlus is a Dutch listed company focused on the development of its proprietary drug formulation technologies, enhancing efficacy by applying liposomes and microspheres
  • Main transaction rationale for Dr. Reddy’s is to get access to the knowledge and capabilities of OctoPlus
  • Kempen & Co acted as financial adviser to Dr. Reddy’s